BiTE significantly enhanced the cytotoxicity of T lymphocytes against CCA cells, especially after gemcitabine treatment, and the magnitude of cytotoxicity was positively correlated with the expression level of PD-L1. This evidence concerns the gene CD274 and cholangiocarcinoma.